Title

CEoT 2022

"Defining Success in Organ Transplantation:  Where Do We Go From Here?”
 

What will be discussed at CEoT?

CEoT 2022 will be an exciting exploration of primary stakeholders in organ transplantation coming together to define ideal metrics to drive equity and quality in transplant access and outcomes and discuss the key challenges that the transplant field must overcome to develop and implement these quality metrics in clinical practice.

The stage will be set by looking at current definitions of success from all key stakeholders - federal, insurers, patients, care providers and understanding the implications of having different stakeholders whose perspectives on success do not always align. The program will then delve into potential alternatives definitions of success at the societal and systems levels as well as for patients and caregivers. Tying in the themes from the ASHI meeting that CEOT 2022 immediately follows, each organ and the infectious disease group with specialized tracks will delve into the Yin and Yang of infection and rejection on the spectrum of immunosuppression. The overarching goal is to systematically examine and refine definitions of success for all stakeholders in transplantation to inform and reframe future conversations in organ transplantation.

CEoT 2022 Program

For those that registered for CEoT 2022, you will have access to the platform and recorded sessions here until June 8, 2022:

CLICK HERE TO ACCESS THE CEOT MEETING PLATFORM 

For information on claiming enduring CME credits: 

VISIT OUR ACCREDITATION PAGE